These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 2883295)
1. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295 [TBL] [Abstract][Full Text] [Related]
2. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [TBL] [Abstract][Full Text] [Related]
3. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. Ricaurte GA; Martello AL; Katz JL; Martello MB J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470 [TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824 [TBL] [Abstract][Full Text] [Related]
5. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986 [TBL] [Abstract][Full Text] [Related]
6. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X; Baumann MH; Xu H; Rothman RB Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556 [TBL] [Abstract][Full Text] [Related]
8. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Battaglia G; Yeh SY; De Souza EB Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449 [TBL] [Abstract][Full Text] [Related]
9. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155 [TBL] [Abstract][Full Text] [Related]
10. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT. Rodsiri R; Green AR; Marsden CA; Fone KC J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941 [TBL] [Abstract][Full Text] [Related]
11. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies. De Souza EB; Battaglia G NIDA Res Monogr; 1989; 94():196-222. PubMed ID: 2575225 [TBL] [Abstract][Full Text] [Related]
12. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R; Kerans A; O'Neill B; Harkin A Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304 [TBL] [Abstract][Full Text] [Related]
14. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. Stone DM; Johnson M; Hanson GR; Gibb JW J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215 [TBL] [Abstract][Full Text] [Related]
15. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD; Nichols DE; Yim GK Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126 [TBL] [Abstract][Full Text] [Related]
16. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Kleven MS; Woolverton WL; Seiden LS Brain Res; 1989 May; 488(1-2):121-5. PubMed ID: 2472850 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Zhang L; Shirayama Y; Shimizu E; Iyo M; Hashimoto K Eur J Pharmacol; 2006 Aug; 544(1-3):1-9. PubMed ID: 16859675 [TBL] [Abstract][Full Text] [Related]
18. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Darvesh AS; Gudelsky GA Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955 [TBL] [Abstract][Full Text] [Related]
20. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. Sabol KE; Lew R; Richards JB; Vosmer GL; Seiden LS J Pharmacol Exp Ther; 1996 Feb; 276(2):846-54. PubMed ID: 8632358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]